Prevalence of Arterial Hypertension in Pediatric Hospitalized Patients

Overview

Journal Arch Cardiol Mex

Specialty Cardiology & Vascular Diseases

Date 2023 Feb 9

PMID 36757775

Authors

Diana C Chacon-Jaimes

Carol L Morales-Contreras

Jazmin Abad

Laura Nino-Serna

Catalina Velez-Echeverri

Affiliations

Soon will be listed here.

Abstract

Objective: To establish the prevalence of arterial hypertension in pediatric patients hospitalized in a tertiary hospital center in Medellin, Colombia for 6 years.

Methods: A descriptive cross-sectional study was carried out that reviewed retrospective information obtained from the clinical records of patients under 18 years of age hospitalized at the Pablo Tobón Uribe Hospital in Medellín.

Results: From a total of 382 pediatric patients hospitalized in the studied period, a prevalence of hypertension of 30.6% was found. Systolic hypertension prevalence was 23.6% and diastolic 20.7%. Age under 5, treatment with vancomycin and critical care admission increased the risk of being hypertensive during hospitalization.

Conclusions: In children the frequency of hypertension in hospitalized patients is higher than the prevalence reported in outpatients. The highest risk group and potentially modifiable factors must be recognized and treatment administered in a timely manner. Secondary complications are low, except for left ventricular hypertrophy, which requires long-term follow-up.

Citing Articles

[Letter to the editor regarding "Prevalence of arterial hypertension in hospitalized pediatric patients"].

Almora-Orellana M, Espinoza-Guevara J Arch Cardiol Mex. 2024; 94(2):261-262.

PMID: 38359469 PMC: 11160550. DOI: 10.24875/ACM.23000233.

Left ventricular hypertrophy detected in hospitalized pediatric patients. A concerning finding.

Perez-Fernandez G Arch Cardiol Mex. 2023; 93(3):384-386.

PMID: 37553105 PMC: 10406483. DOI: 10.24875/ACM.23000094.

References

Holt T, Withington D, Mitchell E . Which pressure to believe? A comparison of direct arterial with indirect blood pressure measurement techniques in the pediatric intensive care unit. Pediatr Crit Care Med. 2011; 12(6):e391-4. DOI: 10.1097/PCC.0b013e3182230f43. View

Styne D . Childhood and adolescent obesity. Prevalence and significance. Pediatr Clin North Am. 2001; 48(4):823-54, vii. DOI: 10.1016/s0031-3955(05)70344-8. View

Ehrmann B, Selewski D, Troost J, Hieber S, Gipson D . Hypertension and health outcomes in the PICU. Pediatr Crit Care Med. 2014; 15(5):417-27. PMC: 4117213. DOI: 10.1097/PCC.0000000000000126. View

Mitsnefes M . Hypertension in children and adolescents. Pediatr Clin North Am. 2006; 53(3):493-512, viii. DOI: 10.1016/j.pcl.2006.02.008. View

Alperstein W, Corrales-Medina F, Tamariz L, Palacio A, Davis J . Prevalence of Hypertension (HTN) and Cardiovascular Risk Factors in a Hospitalized Pediatric Hemophilia Population. J Pediatr Hematol Oncol. 2017; 40(3):196-199. DOI: 10.1097/MPH.0000000000001036. View

Flynn J, Kaelber D, Baker-Smith C, Blowey D, Carroll A, Daniels S . Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3). DOI: 10.1542/peds.2017-1904. View

Stein D, Ferguson M . Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016; 9:49-58. PMC: 4803257. DOI: 10.2147/IBPC.S50640. View

McNiece K, Poffenbarger T, Turner J, Franco K, Sorof J, Portman R . Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007; 150(6):640-4, 644.e1. DOI: 10.1016/j.jpeds.2007.01.052. View

Bancalari R, Diaz C, Martinez-Aguayo A, Aglony M, Zamorano J, Cerda V . [Prevalence of hypertension in school age children and its association with obesity]. Rev Med Chil. 2011; 139(7):872-9. DOI: /S0034-98872011000700007. View

10.

Ilivitzki A, Glozman L, Lopez Alfonso R, Ofer A, Beck Razi N, Rotman Shapira M . Sonographic evaluation of renovascular hypertension in the pediatric population: State-of-the-art. J Clin Ultrasound. 2017; 45(5):282-292. DOI: 10.1002/jcu.22467. View

11.

Ewald D, Haldeman PhD L . Risk Factors in Adolescent Hypertension. Glob Pediatr Health. 2016; 3:2333794X15625159. PMC: 4784559. DOI: 10.1177/2333794X15625159. View

12.

Kocher K, Tumin D, Lehmann A, Gomez Mendez L . Identification of hypertension in hospitalized children prescribed as-needed antihypertensive medication. J Clin Hypertens (Greenwich). 2020; 22(8):1452-1457. PMC: 8029683. DOI: 10.1111/jch.13950. View

13.

. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76. View

14.

Louis C, Butani L . High blood pressure and hypertension in children with newly diagnosed acute leukemia and lymphoma. Pediatr Nephrol. 2008; 23(4):603-9. DOI: 10.1007/s00467-007-0720-y. View

15.

Kit B, Kuklina E, Carroll M, Ostchega Y, Freedman D, Ogden C . Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015; 169(3):272-9. PMC: 7423159. DOI: 10.1001/jamapediatrics.2014.3216. View

16.

McWilliam S, Antoine D, Smyth R, Pirmohamed M . Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol. 2016; 32(11):2015-2025. PMC: 5624973. DOI: 10.1007/s00467-016-3533-z. View

17.

. Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics. 1987; 79(1):1-25. View

18.

Chandar J, Zilleruelo G . Hypertensive crisis in children. Pediatr Nephrol. 2011; 27(5):741-51. DOI: 10.1007/s00467-011-1964-0. View

19.

Esbenshade A, Simmons J, Koyama T, Koehler E, Whitlock J, Friedman D . Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010; 56(3):372-8. PMC: 3713225. DOI: 10.1002/pbc.22782. View

20.

Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A . Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012; 68(9):1243-55. DOI: 10.1007/s00228-012-1259-9. View